SLC27A2 and neoplasm: Altogether, these results indicate that GTN and GTN/doxorubicin affect the ROS-mediated cleavage of STAT5, likely lead to the regulation of FATP2 and underlie the increased efficacy of doxorubicin/GTN against tumor growth.